Evidence map›Paper›PMID 36528677›Full record

ArticleBMC health services research2022

"After viral load testing, I get my results so I get to know which path my life is taking me": qualitative insights on routine centralized and point-of-care viral load testing in western Kenya from the Opt4Kids and Opt4Mamas studies.

Shirley Rui W Qian, Shukri A Hassan, Andrea J Scallon, Patrick Oyaro, Evelyn Brown, James Wagude, Irene Mukui, Eunice Kinywa, Frederick Oluoch, Francesca Odhiambo and 9 more

Registry-linked trialOpen access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03820323 (Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03820323 nacompletednot on this map

Optimizing Viral Load Suppression in Kenyan Children on Antiretroviral Therapy

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2019 to 2020Enrolled704ConditionsChronic HIV InfectionArmsPOC VL and targeted DRM testing., SOC VL testing
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of HIV Nucleic Acid Assays in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. "Diagnostics (Basel, Switzerland) · 2023
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Shirley Rui W Qian *School of Public Health, University of Washington, Seattle, WA, USA.
Shukri A Hassan *Department of Medicine, University of Washington, Seattle, WA, USA.
Andrea J ScallonJackson School of International Studies, University of Washington, Seattle, WA, USA.
Patrick OyaroHealth Innovations Kenya (HIK), Kisumu, Kenya.
Evelyn BrownUniversity of Washington-Kenya, Nairobi, Kenya.
James WagudeDepartment of Health, Siaya, Kenya.
Irene MukuiDrugs for Neglected Diseases Initiative, Nairobi, Kenya.
Eunice KinywaDepartment of Health, Kisumu, Kenya.
Frederick OluochDepartment of Health, Kisumu, Kenya.
Francesca OdhiamboFamily AIDS Care and Education Services, Kenya Medical Research Institute, Kisumu, Kenya.
Boaz OyaroKenya Medical Research Institute-CDC, Kisian, Kenya.
Leonard KingwaraNational HIV Reference Laboratory, Kenya Ministry of Health, Nairobi, Kenya.
Nashon YongoUniversity of Washington-Kenya, Nairobi, Kenya.
Enericah KaraukiUniversity of Washington-Kenya, Nairobi, Kenya.
Jody GaoSchool of Public Health, University of Washington, Seattle, WA, USA.
Lindah OtienoFamily AIDS Care and Education Services, Kenya Medical Research Institute, Kisumu, Kenya.
Grace C John-StewartDepartment of Medicine, University of Washington, Seattle, WA, USA.
Lisa L AbuogiDepartment of Pediatrics, University of Colorado, Denver, CO, USA.
Rena C PatelDepartment of Medicine, University of Washington, Seattle, WA, USA. rcpatel@uw.edu.
University of Washington · USKenya Medical Research Institute · KEUniversity of Nairobi · KEGreat Lakes University of Kisumu · KEKenya AIDS Vaccine Initiative · KEMinistry of Health · KEUniversity of Colorado Denver · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Optimizing viral load suppression in Kenyan children on antiretroviral therapy (Opt4Kids)R34MH115769 · NIMH · UNIVERSITY OF WASHINGTON · PI ABUOGI, LISA LYNN, PATEL, RENA CHIMAN · 2018 to 2019
$698k
Optimizing viral suppression for pregnant and postpartum women living with HIV through HIV resistance testing (Opt4Mamasplus)R21AI145450 · NIAID · UNIVERSITY OF WASHINGTON · PI PATEL, RENA CHIMAN · 2019 to 2020
$453k
NIAID NIH HHS P30 AI027757NIAID NIH HHS R21 AI145450NIMH NIH HHS R34 MH115769
6 · The paper itself

Abstract

backgroundViral suppression (VS) is a marker of effective HIV therapy, and viral load (VL) testing is critical for treatment monitoring, especially in high-risk groups such as children and pregnant/postpartum women. Although routine VL testing, via centralized laboratory networks, was implemented in Kenya starting in 2014, optimization and sustainable scale up of VL testing are still needed.

methodsWe conducted a mixed methods study to evaluate the impact of higher frequency, point-of-care (POC) VL testing in optimizing VS among children and pregnant/postpartum women on antiretroviral treatment (ART) in five HIV treatment facilities in western Kenya in the Opt4Kids and Opt4Mamas studies. We conducted 68 key informant interviews (KIIs) from December 2019 to December 2020 with children and pregnant women living with HIV, child caregivers, providers, laboratory/facility leadership, and county- or national-level policymakers. Our KII guide covered the following domains: (1) barriers and facilitators to ART use and VS, (2) literacy and experiences with VL in routine care and via study, and (3) opinions on how to scale up VL testing for optimal programmatic use. We used inductive coding and thematic analysis to identify dominant themes with convergent and divergent subthemes.

resultsThree main themes regarding VL testing emerged from our analysis. (1) Key informants uniformly contrasted POC VL testing's faster results turnaround, higher accessibility, and likely cost-effectiveness against centralized VL testing. (2) Key informants also identified areas of improvement for POC VL testing in Kenya, such as quality control, human resource and infrastructure capacity, supply chain management, and integration of VL testing systems. (3) To enable successful scale-up of VL testing, key informants proposed expanding the POC VL testing scheme, electronic medical records systems, conducting quality checks locally, capacity building and developing strong partnerships between key stakeholders.

conclusionThe more accessible, decentralized model of POC VL testing was deemed capable of overcoming critical challenges associated with centralized VL testing and was considered highly desirable for optimizing VS for children and pregnant/postpartum women living with HIV. While POC VL testing has the potential to improve VS rates among these populations, additional research is needed to develop strategies for ensuring the sustainability of POC VL testing programs.

trial registrationNCT03820323, 29/01/2019.

Indexed as

Anti-HIV AgentsHIV InfectionsAnti-Retroviral AgentsChildFemaleHumansKenyaPoint-of-Care SystemsPoint-of-Care TestingPregnancyViral LoadAnti-HIV AgentsAnti-Retroviral AgentsChildrenKenyaPoint-of-carePregnant/postpartum womenViral load testingViral suppression

Identifiers

PMID36528677
PMCPMC9758673
OpenAlexW4312114183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.